組織工学市場- 世界の産業規模、シェア、動向、機会、予測、材料タイプ別、用途別、エンドユーザー別、地域別、競合別、2020～2030年

組織工学の世界市場規模は2024年に135億米ドルとなり、2030年までのCAGRは9.20％と、大きな成長が予測されています。

組織工学は、再生医療とバイオテクノロジーの中でもダイナミックで急速に進化する分野となっています。この分野は、生物学、化学、工学の原理を応用して、医療用に機能的な組織や臓器を創り出すものです。市場の成長は、臓器移植の需要の増加、ドナー臓器の不足、高度な治療ソリューションの必要性によって牽引されています。

組織工学市場拡大の主な要因は、心血管疾患、糖尿病、整形外科疾患などの慢性疾患や傷害の罹患率の上昇です。組織工学は、これらの重要な健康問題に対処する、人工臓器、組織、インプラントを含む、患者に特化した治療開発のための革新的なソリューションを提供しています。さらに、高齢者が生活の質を高めるために組織ベースの治療を頻繁に必要とするため、世界人口の高齢化が市場の成長にさらに貢献しています。

バイオテクノロジー、生体材料、3Dプリンティングの技術的進歩は、組織工学を新たなレベルに押し上げています。企業や研究者は、自然の臓器を忠実に模倣した複雑で機能的な組織を作り、移植の成功率を高め、拒絶反応のリスクを軽減するために、これらの技術革新をますます活用するようになっています。幹細胞調査、CRISPR-Cas9のような遺伝子編集技術、生体適合性材料の統合は、組織工学の個別化医療アプローチへの道を開いた。

世界の組織工学市場は、皮膚移植片、骨や軟骨の修復、心臓弁、さらには腎臓や肝臓などの臓器全体など、幅広い用途を特徴としています。これらの用途は整形外科から皮膚科、循環器科まで様々な医療分野に及んでおり、市場の多用途性と成長の可能性を浮き彫りにしています。

主要市場促進要因

慢性疾患と傷害の有病率の上昇

主な市場課題

複雑な規制枠組み

主な市場動向

多様なアプリケーション

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の組織工学市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 材料タイプ別（合成材料、生物由来材料、その他）
  • 用途別（整形外科、筋骨格・脊椎、神経学、心臓学、皮膚・外皮、その他）
  • エンドユーザー別（病院、がん研究センター、学術調査機関、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ
  • 材料タイプ別
  • 用途別
  • エンドユーザー別
  • 地域別

第5章 アジア太平洋地域の組織工学市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 材料タイプ別
  • 用途別
  • エンドユーザー別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州の組織工学市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米の組織工学市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米の組織工学市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカの組織工学市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第12章 世界の組織工学市場：SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Zimmer Biomet Holdings Inc.
• Stryker Corporation Holdings
• 3D BioFibR Inc.
• Integra LifeSciences Corporation
• CollPlant Biotechnologies Ltd.
• AbbVie（Allergan Aesthetics）
• Becton, Dickinson and Company
• Athersys, Inc.
• BioTissue
• Japan Tissue Engineering Co., Ltd

第15章 戦略的提言

第16章 調査会社について・免責事項

The Global Tissue Engineering Market was valued at USD 13.50 billion in 2024 and is projected to experience significant growth, with a compound annual growth rate (CAGR) of 9.20% through 2030. Tissue engineering has become a dynamic and rapidly evolving segment within regenerative medicine and biotechnology. This field involves applying principles from biology, chemistry, and engineering to create functional tissues and organs for medical applications. The market's growth is driven by the increasing demand for organ transplants, a shortage of donor organs, and the need for advanced therapeutic solutions.

A key driver behind the expansion of the tissue engineering market is the rising incidence of chronic diseases and injuries, such as cardiovascular diseases, diabetes, and orthopedic conditions. Tissue engineering offers innovative solutions for the development of patient-specific treatments, including engineered organs, tissues, and implants, addressing these critical health issues. Additionally, the aging global population further contributes to the market's growth, as elderly individuals frequently require tissue-based therapies to enhance their quality of life.

Technological advancements in biotechnology, biomaterials, and 3D printing are propelling tissue engineering to new levels. Companies and researchers are increasingly leveraging these innovations to create complex, functional tissues that closely mimic natural organs, improving transplant success rates and reducing rejection risks. The integration of stem cell research, gene editing techniques such as CRISPR-Cas9, and biocompatible materials has paved the way for personalized medicine approaches within tissue engineering.

The global tissue engineering market is characterized by a broad range of applications, including skin grafts, bone and cartilage repair, heart valves, and even whole organs such as kidneys and livers. These applications span various medical fields, from orthopedics to dermatology and cardiology, highlighting the market's versatility and growth potential.

Key Market Drivers

Rising Prevalence of Chronic Diseases and Injuries

The tissue engineering market is experiencing rapid growth, largely driven by the increasing global prevalence of chronic diseases and injuries. Cardiovascular diseases, which impact the heart and blood vessels, account for 18 million deaths annually worldwide, with cancer causing 9 million deaths and chronic respiratory diseases contributing to 4 million fatalities. Diabetes is responsible for 2 million deaths each year. These figures emphasize the substantial health burden posed by non-communicable diseases, underscoring the critical need for innovative healthcare solutions. As the demand for regenerative treatments grows, tissue engineering is emerging as a crucial component of modern medicine.

Chronic conditions such as cardiovascular diseases, diabetes, orthopedic disorders, and trauma-related injuries necessitate advanced tissue regeneration and organ repair solutions. Tissue engineering offers effective regenerative solutions to repair or replace damaged tissues resulting from these conditions. For example, tissue-engineered blood vessels, heart valves, and cardiac patches are in high demand due to the increasing incidence of cardiovascular complications. Similarly, tissue-engineered skin grafts and cell-based therapies are helping diabetic patients heal chronic wounds and foot ulcers.

As healthcare systems shift focus toward treating chronic illnesses, bioprinted tissues, scaffold-based regenerative treatments, and stem cell therapies are becoming key solutions, further driving the market's expansion.

Key Market Challenges

Complex Regulatory Frameworks

The complex regulatory landscape is a significant challenge to the growth and development of the Global Tissue Engineering Market. While regulations are necessary to ensure the safety and efficacy of medical products, the evolving nature of tissue engineering presents unique obstacles for both industry stakeholders and regulatory bodies. A major challenge is the classification and oversight of tissue-engineered products, which may fall under various regulatory categories, including medical devices, biologics, or combination products, depending on their intended use and composition. This ambiguity often requires engagement with multiple regulatory agencies, each with its own set of requirements, making the process time-consuming and cumbersome.

The lengthy and stringent approval processes for tissue-engineered products are another major hurdle. Regulatory agencies, such as the FDA (Food and Drug Administration) in the United States and the EMA (European Medicines Agency) in Europe, require extensive preclinical and clinical data to demonstrate the safety and efficacy of these products. While this is crucial for patient safety, it can lead to delays in market entry and increased development costs. Additionally, the rapid pace of advancements in tissue engineering often outstrips the ability of regulators to adapt their frameworks, creating uncertainty for companies engaged in R&D.

Key Market Trends

Diverse Range of Applications

The Global Tissue Engineering Market is experiencing significant growth, primarily due to its broad range of applications across various medical fields. Initially focused on repairing and replacing damaged tissues, tissue engineering has expanded to address a wide array of healthcare challenges, driving market growth.

One notable application is in orthopedics and musculoskeletal medicine. Tissue-engineered solutions are helping patients with bone fractures, cartilage defects, and joint injuries regenerate these essential structures. Advanced biomaterials and scaffold designs are enabling the creation of custom-made bone grafts and cartilage implants that integrate seamlessly with patients' tissues, improving mobility and reducing pain.

In dermatology, tissue-engineered skin substitutes are offering effective solutions for chronic wounds, burns, and skin defects. These skin grafts promote tissue regeneration, enhance healing, and reduce scarring. In cardiology, tissue-engineered heart valves and cardiac patches hold significant potential, offering alternatives to traditional treatments and improving cardiac function.

Beyond these areas, tissue engineering is also making strides in ophthalmology, neurology, and urology. For instance, tissue-engineered corneas are being developed to treat vision impairments, while neural tissue engineering is targeting spinal cord injuries and neurodegenerative disorders. Additionally, tissue-engineered bladders and urethras are being explored to address urinary tract conditions.

Key Market Players

• Zimmer Biomet Holdings Inc.
• Stryker Corporation
• 3D BioFibR Inc.
• Integra LifeSciences Corporation
• CollPlant Biotechnologies Ltd.
• AbbVie (Allergan Aesthetics)
• Becton, Dickinson and Company
• Athersys, Inc.
• BioTissue
• Japan Tissue Engineering Co., Ltd.

Report Scope

This report segments the Global Tissue Engineering Market based on the following categories:

By Material Type:

• Synthetic Materials
• Biologically Derived Materials
• Others

By Application:

• Orthopedics
• Musculoskeletal & Spine
• Neurology
• Cardiology
• Skin & Integumentary
• Others

By End-User:

• Hospitals
• Cancer Research Centers
• Academic and Research Institutes
• Others

By Region:

• North America (United States, Canada, Mexico)
• Europe (France, United Kingdom, Italy, Germany, Spain)
• Asia-Pacific (China, India, Japan, Australia, South Korea)
• South America (Brazil, Argentina, Colombia)
• Middle East & Africa (South Africa, Saudi Arabia, UAE)

Competitive Landscape and Company Profiles:

The report includes detailed analyses of the major companies operating in the Global Tissue Engineering Market.

Available Customizations:

TechSci Research offers the ability to customize the report according to a company's specific needs, including profiling additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Tissue Engineering Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Material Type (Synthetic Materials, Biologically Derived Materials, Others)
  • 4.2.2. By Application (Orthopedics, Musculoskeletal & Spine, Neurology, Cardiology, Skin & Integumentary, Others)
  • 4.2.3. By End User (Hospitals, Cancer Research Centers, Academic and Research Institutes, Others)
  • 4.2.4. By Region
  • 4.2.5. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Material Type
  • 4.3.2. By Application
  • 4.3.3. By End User
  • 4.3.4. By Region

5. Asia Pacific Tissue Engineering Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Material Type
  • 5.2.2. By Application
  • 5.2.3. By End User
  • 5.2.4. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Tissue Engineering Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Material Type
      • 5.3.1.2.2. By Application
      • 5.3.1.2.3. By End User
  • 5.3.2. India Tissue Engineering Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Material Type
      • 5.3.2.2.2. By Application
      • 5.3.2.2.3. By End User
  • 5.3.3. Australia Tissue Engineering Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Material Type
      • 5.3.3.2.2. By Application
      • 5.3.3.2.3. By End User
  • 5.3.4. Japan Tissue Engineering Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Material Type
      • 5.3.4.2.2. By Application
      • 5.3.4.2.3. By End User
  • 5.3.5. South Korea Tissue Engineering Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Material Type
      • 5.3.5.2.2. By Application
      • 5.3.5.2.3. By End User

6. Europe Tissue Engineering Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Material Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Tissue Engineering Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Material Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Germany Tissue Engineering Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Material Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Spain Tissue Engineering Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Material Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User
  • 6.3.4. Italy Tissue Engineering Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Material Type
      • 6.3.4.2.2. By Application
      • 6.3.4.2.3. By End User
  • 6.3.5. United Kingdom Tissue Engineering Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Material Type
      • 6.3.5.2.2. By Application
      • 6.3.5.2.3. By End User

7. North America Tissue Engineering Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Material Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Tissue Engineering Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Material Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. Mexico Tissue Engineering Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Material Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. Canada Tissue Engineering Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Material Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User

8. South America Tissue Engineering Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Material Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Tissue Engineering Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Material Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. Argentina Tissue Engineering Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Material Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Colombia Tissue Engineering Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Material Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User

9. Middle East and Africa Tissue Engineering Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Material Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Tissue Engineering Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Material Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Saudi Arabia Tissue Engineering Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Material Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. UAE Tissue Engineering Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Material Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Tissue Engineering Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Zimmer Biomet Holdings Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (In case of listed)
  • 14.1.5. Recent Developments
  • 14.1.6. SWOT Analysis
• 14.2. Stryker Corporation Holdings
• 14.3. 3D BioFibR Inc.
• 14.4. Integra LifeSciences Corporation
• 14.5. CollPlant Biotechnologies Ltd.
• 14.6. AbbVie (Allergan Aesthetics)
• 14.7. Becton, Dickinson and Company
• 14.8. Athersys, Inc.
• 14.9. BioTissue
• 14.10. Japan Tissue Engineering Co., Ltd

15. Strategic Recommendations

16. About Us & Disclaimer